Abstract
Patents are designed to protect and encourage creativity and innovation. Patenting a biomedical discovery can be a requirement before a pharmaceutical company or biotech entity will invest in the lengthy and costly clinical testing necessary to achieve patient benefit. Although scientists and clinicians are well versed in research publication requirements, patent descriptions and claims are formatted in a manner quite different from a research paper. Patents require (a) a series of logical statements clearly delineating the boundaries of the novel aspects of the invention and (b) sufficient disclosure of the invention so that it can be reproduced by others. Patents are granted only for inventions that meet three conditions: novelty, nonobviousness, and usefulness. This chapter provides basic guidelines and definitions of technology transfer: inventions, inventorship, and patent filing, which are summarized using a question and answer format.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Jones, B. W. (2006) Broadening the Scope of Inherent Anticipation and Its Impact on the Patentability of Chemical Structures, Comment, SmithKline v. Apotex. 5J MARSHALL REV INTELL PROP L 456, 455–476.
Gholz, C. L. (2007) A Critique of Recent Opinions in Patent Interferences. J Pat & Trademark Office Society 89, 1–43.
Merges, R. P. (1999) The Law and Economics of Employee Inventions. Harvard Journal of Law and Technology 13, 1–53.
Kelton, T. (2007) Pharmacogenomics:The rediscovery of the concept of tailored drug therapy and personalized medicine. The Health Lawyer 19, 1–10.
Shi, Q. (2005) Patent System Meets New Sciences: Is the Law Responsive to Changing Technologies and Industries? NYU Annual Survey of American Law 61, 317–346.
(2011) General information about patents in Patent Information Tour. Accessed March 8, 2011, http://www.european-patent-office.org/wbt/pi-tour/tour.php.
Ledford, H. (2010) US government wants limits on gene patents in Nature News. Accessed March 6, 2011, http://www.nature.com/news/2010/101102/full/news.2010.576.html.
Wadman, M. (2010) Breast cancer gene patents judged invalid in Nature News. Accessed March 6, 2011, http://www.nature.com/news/2010/100330/full/news.2010.160.html.
Dolak, L. A. (1999) Patents Without Paper: Proving a Date of Invention With Electronic Evidence. Houston Law Review 36, 472–530.
Gholz, C. L. (2000) First-to-File or First-to-Invent? J Pat & Trademark Office Society 82, 891–895.
(2007) Title 35 Patent Laws in United States Code Title 35-Patents.
Matt, J. (2002) Searching for an Efficacious Joint Inventorship Standard. Boston College Law Review 44, 245–287.
(2011) Title 37 Patents, Trademarks, and Copyrights in United States Code Title 37 Parts 1–199.
(2010) Manual of Patent Examining Procedure (MPEP)March 6, 2011, http://www.uspto.gov/web/offices/pac/mpep/index.htm.
Adamo, K. R., McCrum, R. B., Gerber, S. M. (2007) The Curse of “Copying”. 7J MARSHALL REV INTELL PROP L 296, 296–324.
Acknowledgment
The authors thank Richard Peet for invaluable discussion regarding patent law and intellectual property.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Tidwell, J.L., Liotta, L.A. (2012). Inventions and Patents: A Practical Tutorial. In: Espina, V., Liotta, L. (eds) Molecular Profiling. Methods in Molecular Biology, vol 823. Humana Press. https://doi.org/10.1007/978-1-60327-216-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-60327-216-2_26
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-215-5
Online ISBN: 978-1-60327-216-2
eBook Packages: Springer Protocols